Forbes - Business
Moderna Shares Slump As Citi Downgrades To 'Sell’ After Cancer Vaccine Rally
Moderna stock has rallied more than 200% since August, following positive Phase 3 trial results for a melanoma vaccine.
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.